EU Seals Deal for Up to 1.8 bn Extra BioNTech/Pfizer Doses

The EU has concluded a deal with BioNTech/Pfizer for up to 1.8 billion extra doses of its Covid-19 vaccine, European Commission chief Ursula von der Leyen said on Saturday.

"Happy to announce that the EU Commission has just approved a contract for guaranteed 900 million doses (+900 million options) with BioNTech/Pfizer for 2021-2023," she tweeted from an EU summit in Portugal.

"Other contracts and other vaccine technologies will follow," she promised.